Omnicell (OMCL) Shares Outstanding (Weighted Average) (2010 - 2026)
Omnicell (OMCL) reported Shares Outstanding (Weighted Average) of $45.3 million for Q1 2026, down 2.73% year-over-year from $46.6 million in Q1 2025, and down 1.4% quarter-over-quarter from $46.0 million in Q4 2025.
Omnicell (OMCL) Shares Outstanding (Weighted Average) (2010 - 2026) Analysis & Trends
Omnicell (OMCL) has 17 years of Shares Outstanding (Weighted Average) data on file, last reported at $45.3 million in Q1 2026.
- Shares Outstanding (Weighted Average) for Q1 2026 came in at $45.3 million, down 2.73% year-over-year; the trailing twelve-month figure through Mar 2026 was $45.3 million (down 2.73% YoY), and the FY2025 annual result was $46.0 million, changed 0.18% from the prior year.
- Shares Outstanding (Weighted Average) eased to $45.3 million in Q1 2026 per OMCL's latest filing, from $46.0 million in the prior quarter.
- Over five years, Shares Outstanding (Weighted Average) peaked at $46.7 million in Q2 2025 and troughed at $44.2 million in Q2 2022.
- A 5-year average of $45.4 million and a median of $45.3 million in 2026 frame the typical range for Shares Outstanding (Weighted Average).
- The sharpest annual moves came in 2022 and 2026: Shares Outstanding (Weighted Average) increased 3.0% in 2022, then dropped 2.73% in 2026.
- A 5-year view of Shares Outstanding (Weighted Average) shows it stood at $44.4 million in 2022, then climbed by 1.83% to $45.2 million in 2023, then rose by 1.85% to $46.0 million in 2024, then dropped by 0.18% to $46.0 million in 2025, then declined by 1.4% to $45.3 million in 2026.
- Business Quant data shows OMCL's Shares Outstanding (Weighted Average) at $45.3 million in Q1 2026, $46.0 million in Q4 2025, and $45.5 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Weighted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn | 163.35 Mn |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn | 204.71 Mn |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn | 84.41 Mn |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn | 78.62 Mn |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn | 128.29 Mn |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn | 187.01 Mn |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn | 191.67 Mn |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn | 124.15 Mn |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn | 45.32 Mn |
| 10 | Teladoc Health | 1.45 Bn | 696.57 Mn | 562.57 Mn | 179.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 45.32 Mn |
| Dec 31, 2025 | 45.97 Mn |
| Sep 30, 2025 | 45.54 Mn |
| Jun 30, 2025 | 46.69 Mn |
| Mar 31, 2025 | 46.60 Mn |
| Dec 31, 2024 | 46.05 Mn |
| Sep 30, 2024 | 46.15 Mn |
| Jun 30, 2024 | 45.95 Mn |
| Mar 31, 2024 | 45.73 Mn |
| Dec 31, 2023 | 45.21 Mn |
| Sep 30, 2023 | 45.12 Mn |
| Jun 30, 2023 | 45.01 Mn |
| Mar 31, 2023 | 44.89 Mn |
| Dec 31, 2022 | 44.40 Mn |
| Sep 30, 2022 | 44.30 Mn |
| Jun 30, 2022 | 44.23 Mn |
| Mar 31, 2022 | 44.25 Mn |
| Dec 31, 2021 | 43.48 Mn |
| Sep 30, 2021 | 43.29 Mn |
| Jun 30, 2021 | 43.26 Mn |